DK198086A - Syntetisk peptid og fremgangsmaade til anvendelse af dette til paavisning af antistoffer mod htlv-iii, diagnosticering af aids og aids-forstadier og som vaccine mod aids og aids-forstadier - Google Patents

Syntetisk peptid og fremgangsmaade til anvendelse af dette til paavisning af antistoffer mod htlv-iii, diagnosticering af aids og aids-forstadier og som vaccine mod aids og aids-forstadier Download PDF

Info

Publication number
DK198086A
DK198086A DK198086A DK198086A DK198086A DK 198086 A DK198086 A DK 198086A DK 198086 A DK198086 A DK 198086A DK 198086 A DK198086 A DK 198086A DK 198086 A DK198086 A DK 198086A
Authority
DK
Denmark
Prior art keywords
aids
aid substances
diagnostication
iii
procedure
Prior art date
Application number
DK198086A
Other languages
English (en)
Other versions
DK198086D0 (da
Inventor
Chang Yi Wang
James Jian Guang Wang
Original Assignee
United Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/847,102 external-priority patent/US4735896A/en
Application filed by United Biomedical Inc filed Critical United Biomedical Inc
Publication of DK198086D0 publication Critical patent/DK198086D0/da
Publication of DK198086A publication Critical patent/DK198086A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK198086A 1985-09-11 1986-04-30 Syntetisk peptid og fremgangsmaade til anvendelse af dette til paavisning af antistoffer mod htlv-iii, diagnosticering af aids og aids-forstadier og som vaccine mod aids og aids-forstadier DK198086A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77464485A 1985-09-11 1985-09-11
US83756686A 1986-03-04 1986-03-04
US06/847,102 US4735896A (en) 1986-03-04 1986-04-02 Synthetic peptide and process of using same for the detection and diagnosis of AIDS and pre-AIDS conditions

Publications (2)

Publication Number Publication Date
DK198086D0 DK198086D0 (da) 1986-04-30
DK198086A true DK198086A (da) 1987-03-12

Family

ID=27419712

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198086A DK198086A (da) 1985-09-11 1986-04-30 Syntetisk peptid og fremgangsmaade til anvendelse af dette til paavisning af antistoffer mod htlv-iii, diagnosticering af aids og aids-forstadier og som vaccine mod aids og aids-forstadier

Country Status (9)

Country Link
EP (1) EP0214709B1 (da)
JP (1) JP2702911B2 (da)
AU (1) AU579467B2 (da)
DE (2) DE3689097T2 (da)
DK (1) DK198086A (da)
ES (1) ES8801839A1 (da)
HK (1) HK95194A (da)
IL (1) IL78696A (da)
NO (1) NO176798C (da)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
DE3689941D1 (de) * 1985-10-24 1994-08-04 Southwest Found Biomed Res Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc.
NZ218050A (en) * 1985-11-13 1989-05-29 Wistar Inst Test for the presence of htlv-1v
WO1987006005A1 (en) * 1986-03-24 1987-10-08 Ortho Pharmaceutical Corporation Synthetic htlv-iii peptides, compositions and uses thereof
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
EP0247557B1 (en) * 1986-05-27 1994-04-20 F. Hoffmann-La Roche Ag HTLV-III(LAV) Envelope peptides
US5017688A (en) * 1986-06-12 1991-05-21 Biogen, Inc. Peptides involved in the pathogenesis of HIV infection
US4943627A (en) * 1986-06-12 1990-07-24 Biogen, Inc. Peptides involved in the pathogenesis of HIV infection
US5087557A (en) * 1986-06-23 1992-02-11 Genetic Systems Corporation Human monoclonal antibody to lymphadenopathy-associated virus
DK169582B1 (da) * 1986-06-23 1994-12-12 Squibb Bristol Myers Co Humant monoklonalt antistof, der er i stand til at reagere med en epitop på LAV/HTLV-III kappeglycoproteinet gp41, cellelinier, som producerer sådant antistof, farmaceutisk præparat indeholdende antistoffet samt fremgangsmåde til bestemmelse af nærværelsen af LAV/HTLV-III i en biologisk prøve og fremgangsmåde til separering af specifikke antigendeterminanter af LAV/HTLV-III under anvendelse af ant
AU7786387A (en) * 1986-07-21 1988-02-10 Southwest Foundation For Biomedical Research Composition of matter and method of immunizing against viral causative agents of aids and arc
FR2610632B1 (fr) * 1987-02-11 1990-12-21 Pasteur Institut Peptides caracteristiques des retrovirus d'immunodeficience humaine (virus hiv) leurs applications au diagnostic des infections dues a certains de ces virus et, le cas echeant, a la vaccination contre le sida
DE3850593T3 (de) * 1987-03-25 2001-01-04 Genetic Systems Corp., Seattle Synthetische Antigene zur Bestimmung der AIDS-bezogenen, von LAV-2 verursachten Krankheiten.
SE8701628D0 (sv) * 1987-04-16 1987-04-16 Erling Norrby Medel for analys mm
AU1711888A (en) * 1987-04-24 1988-12-02 Biogen, Inc. Immunotherapeutic methods and compositions
US4921787A (en) * 1987-05-01 1990-05-01 Cambridge Bioscience Corporation Detection of antibodies to human immunodeficiency virus by agglutination of antigen coated latex
US5854400A (en) * 1987-05-29 1998-12-29 Tanox, Inc. Monoclonal antibodies which neutralize HIV-1 infection
CA1339857C (en) * 1987-05-29 1998-05-05 Cecily Rou-Yun Sun Monoclonal antibodies to gp120 which neutraleze hiv-1
US6657050B1 (en) 1987-05-29 2003-12-02 Tanox, Inc. Chimeric viral-neutralizing immunoglobulins
SE8704185L (sv) * 1987-10-28 1989-04-29 Ferring Ab Nya peptider, artificiella antigener och immunoanalystestsatser
EP0323157A3 (en) * 1987-12-24 1990-07-25 The University Of Melbourne Antiviral compounds and methods
SE8705197D0 (sv) * 1987-12-30 1987-12-30 Jonas Blomberg New peptides, two diagnostic methods using the peptides and a medicament based on the peptides
US5149623A (en) * 1988-02-09 1992-09-22 Virotest, Inc. Rapid, easy, and economical screening test for antibodies to human immunodeficiency virus
EP0330359A3 (en) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Composition useful in the diagnosis and treating of hiv-1 infection
AU608413B2 (en) * 1988-03-30 1991-03-28 Abbott Laboratories Mouse monoclonal antibody (5-21-3) to human immunodeficiency virus gp41 protein
JPH0292298A (ja) * 1988-09-30 1990-04-03 Olympus Optical Co Ltd Ｈｉｖ構成蛋白に対するモノクローナル抗体
IL94558A0 (en) * 1989-06-06 1991-03-10 Merck & Co Inc Conjugate immunogen for aids and vaccine and pharmaceutical compositions containing it
IL95738A (en) * 1989-09-23 1996-11-14 Hoechst Ag Antibodies against the well-preserved amino acid sequences of insulin, a process for their preparation and use in immunoassay
US6248574B1 (en) * 1989-12-13 2001-06-19 Avigdor Shaffermann Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides
FR2657017B1 (fr) * 1990-01-16 1995-08-18 Clonatec Sa Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-1, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
EP0438332B1 (fr) * 1990-01-16 1998-04-08 Orgenics Ltd. Peptides dérivant de la glycoprotéine d'enveloppe de virus HIV, leurs applications à la détection d'une infection due à ces virus et à la vaccination contre le SIDA
DK0754704T3 (da) * 1990-12-14 2000-04-03 Innogenetics Nv Syntetiske antigener til påvisning af antistoffer mod hepatitis c-virus
US5688768A (en) * 1991-02-19 1997-11-18 Cor Therapeutics, Inc. Recombinant thrombin receptor and related pharmaceuticals
US7119182B1 (en) 1991-02-19 2006-10-10 The Regents Of The University Of California Recombinant thrombin receptor and related pharmaceuticals
US6667387B1 (en) 1996-09-30 2003-12-23 N.V. Innogenetics S.A. HCV core peptides
US6709828B1 (en) 1992-03-06 2004-03-23 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
DK2447252T3 (da) 2004-05-23 2020-03-16 Hmi Medical Innovations Llc Theramuteinmodulatorer
US8431110B2 (en) 2005-05-23 2013-04-30 Hmi Medical Innovations, Llc. Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators
CN102146116B (zh) * 2010-12-30 2013-02-13 桂林医学院 罗汉果甜苷v特异性抗血清的制备及检测方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI83662C (fi) * 1980-07-17 1991-08-12 Scripps Clinic Res Diagnostik antikropp och foerfarande foer dess framstaellning.
JPS62500452A (ja) * 1984-09-19 1987-02-26 ザ　リ−ジエンツ　オブ　ザ　ユニバ−シテイ　オブ　カリフオルニア ヒト細胞形質転換に関連するレトロウイルスポリペプチド
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
FR2580177B2 (fr) * 1985-04-15 1989-06-02 Pasteur Institut Antigenes apparentes a la glycoproteine d'enveloppe du virus du sida, notamment precurseurs de cette glycoproteine, procedes d'obtention de ces antigenes et moyens mis en oeuvre dans ces procedes, applications de ces antigenes a la preparation de compositions immunogenes ou pour le diagnostic du sida ou des affections qui lui sont apparentees
DE3650175T3 (de) * 1985-04-29 2007-09-06 Bio-Rad Laboratories, Inc., Hercules Synthetische antigene zum nachweis von aids.

Also Published As

Publication number Publication date
AU579467B2 (en) 1988-11-24
NO176798C (no) 1995-05-31
NO861697L (no) 1987-03-12
IL78696A (en) 1991-04-15
EP0214709A3 (en) 1988-09-21
DE3689097D1 (de) 1993-11-04
DE214709T1 (de) 1987-10-15
IL78696A0 (en) 1986-08-31
JP2702911B2 (ja) 1998-01-26
ES8801839A1 (es) 1988-02-16
EP0214709B1 (en) 1993-09-29
JPS6261996A (ja) 1987-03-18
AU5680386A (en) 1987-04-16
DK198086D0 (da) 1986-04-30
DE3689097T2 (de) 1994-04-21
ES554592A0 (es) 1988-02-16
HK95194A (en) 1994-09-16
NO176798B (no) 1995-02-20
EP0214709A2 (en) 1987-03-18

Similar Documents

Publication Publication Date Title
DK198086A (da) Syntetisk peptid og fremgangsmaade til anvendelse af dette til paavisning af antistoffer mod htlv-iii, diagnosticering af aids og aids-forstadier og som vaccine mod aids og aids-forstadier
DK210283A (da) Fremgangsmaade til fremstilling af plasma, plasmapraeparat og vaccine mod hepatitis
DK9089D0 (da) Praeparat til vaccine mod kokcidiose
DK168080C (da) Fremgangsmaade til fremstilling af lavmolekylaere peptider
DE3885527D1 (de) Durchlässige Gastrennungsmembranen.
NO893568D0 (no) Siloksanpodede membraner.
DK164088D0 (da) Syntetiske peptidantigener til paavisning af hiv-1-infektion
DK251589D0 (da) Fremgangsmaade til fremstilling af 1,3-dioler
DK110289D0 (da) Fremgangsmaade til fremstilling af cycliske sulfater
DE3851367D1 (de) Ammoniaktrennung mittels halbdurchlässiger Membranen.
DK640989D0 (da) Mikrobiologisk fremgangsmaade til fremstilling af immunundertrykkende antibiotika
DK4189A (da) Oxadiazolforbindelse, farmaceutisk praeparat indeholdende og fremgangsmaade til fremstilling af forbindelsen
DK655489A (da) Fremgangsmaade til fremstilling af et poroest organisk legeme, isaer en semi-permeabel membran
DE3874554D1 (de) Alkalibestaendige hyperfiltrationsmembran.
DK229587A (da) Fremgangsmaade til paavisning af infektion
DE3768089D1 (de) Prospektionsverfahren.
DK145189D0 (da) Fremgangsmaade til fremstilling af heterogene membraner
DE3763368D1 (de) Zusammengesetzte membranen.
NL187870C (nl) Vasthoudring.
DK524489D0 (da) Fremgangsmaade til fremstilling af biologisk aktive forbindelser, specielt enzymer
DK482583A (da) Dna-sekvens, dna-strukturer og fremgangsmaade til fremstilling af penicillin-acylase under anvendelse deraf
DK34888D0 (da) Fremgangsmaade til fremstilling af n,n-(dibenzohexatrienylen)urinstoffer
DK601489D0 (da) Fremgangsmaade til fremstilling af alkansulfonamider
DK240587D0 (da) Fremgangsmaade til fremstilling af kaliummanganat
DK161187A (da) 5-phenyl-5h-indenooe1,2-daapyrimidin og derivater deraf samt fremgangsmaade til fremstilling af saadanneforbindelser.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment